Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...
The study analyzed records of more than 125,000 adults who began taking the GLP-1 drugs liraglutide, semaglutide, or tirzepatide between January 2018 and December 2023. These drugs are prescribed ...
People with fewer side effects, better results stick with these drugs longer The study analyzed records of more than 125,000 adults who began taking the GLP-1 drugs liraglutide, semaglutide ...